Donate Today Log In
American Board of Precision Medicine Blogs
The Future of Medicine Starts Here
Stay ahead with expert perspectives on precision medicine, clinical innovation, and the technologies transforming healthcare.
The Role of Germline Testing in Cancer Risk Assessment

The Role of Germline Testing in Cancer Risk Assessment

American Board of Precision Medicine
Published on: 29/10/2026

Explore how germline testing identifies inherited cancer risk, guides earlier screening and prevention, and provides valuable insights for patients and their families.

Germline TestingHereditary CancerCancer Risk AssessmentGenetic TestingPrecision Oncology
Biomarkers That Matter: The Molecular Signals Guiding Oncology Treatment

Biomarkers That Matter: The Molecular Signals Guiding Oncology Treatment

American Board of Precision Medicine
Published on: 01/10/2026

Discover how molecular biomarkers such as HER2, KRAS, and PD-L1 are helping guide treatment selection, clinical trials, and personalized cancer care.

Precision OncologyCancer BiomarkersMolecular BiomarkersBiomarker TestingPersonalized Cancer Treatment
Polygenic Risk Scores and Cancer Prevention

Polygenic Risk Scores and Cancer Prevention

ABOPM Team
Published on: 27/08/2026

Learn how polygenic risk scores are reshaping cancer prevention by combining thousands of genetic variants to improve risk prediction, personalize screening, and guide earlier preventive care.

Polygenic Risk ScoresCancer PreventionPrecision OncologyGenetic Risk AssessmentPersonalized Cancer Screening
Immunotherapy and Precision Medicine: Personalizing the Immune Response

Immunotherapy and Precision Medicine: Personalizing the Immune Response

ABOPM Team
Published on: 31/07/2026

Discover how precision medicine is transforming immunotherapy through biomarkers like PD-L1, TMB, and MSI-helping clinicians identify the right patients for the right cancer treatments.

Precision OncologyCancer BiomarkersPrecision ImmunotherapyPersonalized Cancer TreatmentImmune Checkpoint Inhibitors
Targeted Therapies in Oncology: Matching Drugs to Mutations

Targeted Therapies in Oncology: Matching Drugs to Mutations

ABOPM Team
Published on: 01/07/2026

Learn how targeted therapies match drugs to cancer-driving mutations, advancing precision oncology and improving treatment outcomes.

Targeted TherapyPrecision OncologyCancer GenomicsMolecular Profiling
Liquid Biopsy and Early Cancer Detection: Promise and Limitations

Liquid Biopsy and Early Cancer Detection: Promise and Limitations

ABOPM Team
Published on: 05/06/2026

Liquid biopsy is transforming cancer detection through minimally invasive genomic testing, offering new opportunities for earlier diagnosis and monitoring.

Precision OncologyLiquid BiopsyEarly Cancer DetectionctDNACancer Genomics

A multidisciplinary community committed to advancing research, education, and clinical standards in precision medicine.

FOLLOW US

LEARN ABOUT THE

ABOPM

CUSTOMER CARE

LEGAL

Copyright 2026. American Board of Precision Medicine. All Rights Reserved.